CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 28, 2026, 4:00 PM EDT
4.180
+0.060 (1.46%)
After-hours: Apr 28, 2026, 7:24 PM EDT
CytomX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 897 | 722 | 81 | 104 | 106 | 283 | |
| Market Cap Growth | 2164.90% | 795.45% | -22.37% | -1.80% | -62.58% | -6.69% | |
| Enterprise Value | 764 | 584 | -26 | -75 | -70 | 69 | |
| Last Close Price | 4.12 | 4.26 | 1.03 | 1.55 | 1.60 | 4.33 | |
| PE Ratio | - | - | 2.53 | - | - | - | |
| Forward PE | - | - | - | 16.30 | - | - | |
| PS Ratio | 11.77 | 9.47 | 0.58 | 1.03 | 1.99 | 7.57 | |
| PB Ratio | 7.08 | 7.29 | -176.77 | -2.19 | -1.23 | -615.53 | |
| P/TBV Ratio | 9.19 | 7.39 | - | - | - | - | |
| EV/Sales Ratio | 10.03 | 7.66 | - | - | - | 1.84 | |
| Debt / Equity Ratio | 0.04 | 0.04 | -20.58 | -0.29 | -0.21 | -47.22 | |
| Debt / EBITDA Ratio | - | - | 0.29 | - | - | - | |
| Net Debt / Equity Ratio | -1.34 | -1.34 | 200.08 | 3.38 | 2.05 | 617.76 | |
| Net Debt / EBITDA Ratio | 7.30 | 7.30 | -3.41 | 37.26 | 1.92 | 2.50 | |
| Net Debt / FCF Ratio | 1.75 | 1.75 | 1.05 | 2.82 | 1.56 | 2.35 | |
| Asset Turnover | 0.56 | 0.56 | 0.86 | 0.44 | 0.18 | 0.11 | |
| Quick Ratio | 2.98 | 2.98 | 1.21 | 1.14 | 1.51 | 3.93 | |
| Current Ratio | 3.09 | 3.09 | 1.25 | 1.17 | 1.55 | 3.99 | |
| Return on Equity (ROE) | -35.25% | -35.25% | - | - | - | - | |
| Return on Assets (ROA) | -8.99% | -8.99% | 9.69% | -1.75% | -19.54% | -20.78% | |
| Return on Capital Employed (ROCE) | -18.60% | -18.60% | 71.90% | -14.10% | -86.70% | -44.40% | |
| Earnings Yield | -2.27% | -2.41% | 39.54% | -0.55% | -93.93% | -41.01% | |
| FCF Yield | -8.45% | -10.50% | -107.36% | -54.78% | -106.42% | -42.70% | |
| Buyback Yield / Dilution | -62.77% | -62.77% | -14.82% | -12.27% | -2.48% | -39.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.